Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ethical Dilemmas II01:30

Ethical Dilemmas II

1.9K
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
1.9K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

207
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
207
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

224
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
224
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

1.7K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.7K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

215
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
215
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

705
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
705

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Donidalorsen for the Treatment of Hereditary Angioedema: A Review of Clinical Studies.

Drug design, development and therapyยท2026
Same author

Therapeutic Targeting of the Bradykinin B2 Receptor in Immunological and Vascular Diseases: Insights from Kinin Biology to Clinical Outcomes.

Clinical reviews in allergy & immunologyยท2026
Same author

Food allergy, biologic therapies, and diagnostic precision: Expanding frontiers in allergy and immunology.

Allergy and asthma proceedingsยท2026
Same author

Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trials.

The World Allergy Organization journalยท2026
Same author

Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary Angioedema.

The New England journal of medicineยท2026
Same author

Social Determinants of Health in Newly Diagnosed Hereditary Angioedema and Their Impact on Healthcare Resource Utilization Outcomes.

The journal of allergy and clinical immunology. In practiceยท2026

Related Experiment Video

Updated: Dec 3, 2025

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.0K

Hereditary angioedema and shared decision making.

Russell A Settipane1, Don A Bukstein2, Marc A Riedl3

  • 1From the Warren Alpert Medical School, Alpert Medical School, Brown University, Providence, Rhode Island.

Allergy and Asthma Proceedings
|October 28, 2020
PubMed
Summary
This summary is machine-generated.

Shared decision-making (SDM) tools are needed to help manage complex hereditary angioedema (HAE) treatments. Developing these tools requires addressing challenges for better patient and practitioner collaboration in HAE care.

More Related Videos

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice
04:29

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice

Published on: May 17, 2024

991

Related Experiment Videos

Last Updated: Dec 3, 2025

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.0K
Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice
04:29

Author Spotlight: Modeling Vascular Contributions to Alzheimer's Disease in Transgenic Mice

Published on: May 17, 2024

991

Area of Science:

  • Clinical Medicine
  • Health Services Research

Background:

  • Hereditary angioedema (HAE) management is complex due to numerous treatment options.
  • Significant morbidity and mortality risks are associated with HAE.
  • Current HAE management lacks adequate tools for shared decision-making (SDM).

Purpose of the Study:

  • To review the principles of SDM.
  • To identify the unmet need for SDM in HAE.
  • To outline the development and implementation of HAE-specific SDM tools.

Main Methods:

  • Literature review of SDM constructs.
  • Analysis of HAE management complexity.
  • Framework development for SDM tool creation and implementation.

Main Results:

  • SDM is crucial for complex HAE treatment decisions.
  • A significant gap exists in SDM support for HAE patients and practitioners.
  • Key steps and challenges for creating and implementing HAE-specific SDM tools were identified.

Conclusions:

  • Developing SDM tools is essential for improving HAE management.
  • Addressing implementation challenges is critical for widespread adoption of SDM in HAE.
  • Enhanced SDM can improve patient outcomes and collaborative care in HAE.